Dongwha Pharm has ranked among the top searched stocks on 2 days within the past month.

As of 12:31 PM on the 8th, Dongwha Pharm is trading at 15,700 KRW, up 6.44% from the previous day. This represents a 61.69% increase compared to May 21. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals such as Gas Hwal Myeong Su and Fusidin.

Today, foreigners have sold a net 50,000 shares of Dongwha Pharm, and institutions have sold a net 12,000 shares, according to provisional data. Over the past 5 days, individual investors have sold a net 150,806 shares, while foreigners and institutions have bought a net 130,755 shares and 35,580 shares, respectively.

On June 5, Dongwha Pharm became a market issue with an 18% rise on news of the COVID-19 treatment 'animal testing imminent.'



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing